🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find the number of natural killer (NK) cell...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2018-05-22
Trial ID
NCT02890758
Treatments Being Tested
This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-07-31
Trial ID
NCT05987696
Treatments Being Tested
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
The aim of this study is the safety and efficacy of cryosurgery plus NK imm...
Status
Completed
Location
Cancer Institute in Fuda cancer hospital
Start Date
2016-07-01
Trial ID
NCT02843815
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641036
Treatments Being Tested
This is a Phase 1 open-label, study designed to characterize the safety, to...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-11-06
Trial ID
NCT05629546
Treatments Being Tested
This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Status
Recruiting
Location
Nkarta Investigational Site
Start Date
2024-06-13
Trial ID
NCT06557265
Treatments Being Tested
T effector cells and NK cells have mutual compensatory killing functions on...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2019-01-01
Trial ID
NCT03882840
Treatments Being Tested
Eligible subjects with advanced hepatocellular carcinoma and ovarian cancer...
Status
Not Yet Recruiting
Location
1st affiliated hospital of Anhui Medical University
Start Date
2026-06
Trial ID
NCT07657416
Treatments Being Tested